It is the earliest gene to be uncovered, and EGFR-TKIs were adopted for clinical work, which markedly changed the therapy strategy and yielded better therapeutic prospects in lung cancer, particularly in adenocarcinoma (9, 10). Here, EGFR is linked to lung carcinoma.